New 4-in-1 shot tested to protect kids from deadly meningitis

NCT ID NCT07135986

Recruiting now ⭐️ VACCINE ⭐️ Sponsor: Sanofi Source: ClinicalTrials.gov ↗

Summary

This study is testing a new vaccine designed to protect against four types of meningococcal bacteria (A, C, Y, W) that can cause serious meningitis and blood infections. It will involve about 1,602 healthy children and adolescents aged 2 to 17 in China. Researchers will compare the new vaccine's safety and ability to trigger a protective immune response against currently licensed vaccines over about six months.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Investigational Site Number : 1561000

    RECRUITING

    Nanning, Guangxi, 530028, China

  • Investigational Site Number : 1561003

    RECRUITING

    Liuchow, 545100, China

Conditions

Explore the condition pages connected to this study.